This preprint has been published elsewhere.
DOI of the published preprint https://doi.org/10.1590/1677-5449.200057
Preprint / Version 1

Can we manage prophylactic therapy in COVID-19 patients to prevent severe illness complications?

##article.authors##

  • Paulo Eduardo Ocke Reis Universidade Federal Fluminense – UFF, Departamento de Cirurgia Geral e Especializada, Niterói, RJ, Brasil https://orcid.org/0000-0001-5450-6806
    • Marcos Cesar Braga Lima Universidade Federal Fluminense – UFF, Departamento de Cirurgia Geral e Especializada, Niterói, RJ, Brasil

      Keywords:

      COVID-19, coronavirus, anticoagulants, thrombosis, prevention, hospital mortality

      Abstract

      Many patients with COVID-19 have thromboembolic complications that worsen their prognosis. Herein, the authors propose a modified version of the CHA2DS2-VASc score, including 1 point for COVID-19, so that prophylaxis to protect against thromboembolic events would be indicated before the condition becomes severe. The advantages of this modification would be prevention of the patient’s condition worsening due to thromboembolic problems and reduction of the likelihood of a need for intensive care and mechanical ventilation, reducing mortality.

      Downloads

      Download data is not yet available.

      Posted

      05/18/2020

      How to Cite

      Can we manage prophylactic therapy in COVID-19 patients to prevent severe illness complications?. (2020). In SciELO Preprints. https://preprints.scielo.org/index.php/scielo/preprint/view/518

      Section

      Health Sciences

      Copyright (c) 2020 Paulo Eduardo Ocke Reis, Marcos Cesar Braga Lima

      Creative Commons License

      This work is licensed under a Creative Commons Attribution 4.0 International License.

      Plaudit